Show simple item record

dc.contributor.authorMortensen, Luke J.
dc.contributor.authorLevy, Oren
dc.contributor.authorPhillips, Joseph P.
dc.contributor.authorStratton, Tara
dc.contributor.authorTriana, Brian
dc.contributor.authorRuiz, Juan P.
dc.contributor.authorGu, Fangqi
dc.contributor.authorLin, Charles
dc.contributor.authorKarp, Jeffrey Michael
dc.date.accessioned2014-01-10T16:24:41Z
dc.date.available2014-01-10T16:24:41Z
dc.date.issued2013-10
dc.date.submitted2013-05
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/1721.1/83858
dc.description.abstractThe ability to deliver cells to appropriate target tissues is a prerequisite for successful cell-based therapy. To optimize cell therapy it is therefore necessary to develop a robust method of in vivo cell delivery quantification. Here we examine Mesenchymal Stem Cells (MSCs) labeled with a series of 4 membrane dyes from which we select the optimal dye combination for pair-wise comparisons of delivery to inflamed tissue in the mouse ear using confocal fluorescence imaging. The use of an optimized dye pair for simultaneous tracking of two cell populations in the same animal enables quantification of a test population that is referenced to an internal control population, thereby eliminating intra-subject variations and variations in injected cell numbers. Consistent results were obtained even when the administered cell number varied by more than an order of magnitude, demonstrating an ability to neutralize one of the largest sources of in vivo experimental error and to greatly reduce the number of cells required to evaluate cell delivery. With this method, we are able to show a small but significant increase in the delivery of cytokine pre-treated MSCs (TNF-α & IFN-γ) compared to control MSCs. Our results suggest future directions for screening cell strategies using our in vivo cell delivery assay, which may be useful to develop methods to maximize cell therapeutic potential.en_US
dc.description.sponsorshipSanofi Aventis (Firm)en_US
dc.language.isoen_US
dc.publisherPublic Library of Scienceen_US
dc.relation.isversionofhttp://dx.doi.org/10.1371/journal.pone.0078145en_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/en_US
dc.sourcePLoSen_US
dc.titleQuantification of Mesenchymal Stem Cell (MSC) Delivery to a Target Site Using In Vivo Confocal Microscopyen_US
dc.typeArticleen_US
dc.identifier.citationMortensen, Luke J., Oren Levy, Joseph P. Phillips, Tara Stratton, Brian Triana, Juan P. Ruiz, Fangqi Gu, Jeffrey M. Karp, and Charles P. Lin. “Quantification of Mesenchymal Stem Cell (MSC) Delivery to a Target Site Using In Vivo Confocal Microscopy.” Edited by Irene Georgakoudi. PLoS ONE 8, no. 10 (October 29, 2013): e78145.en_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.mitauthorKarp, Jeffrey Michaelen_US
dc.relation.journalPLoS ONEen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsMortensen, Luke J.; Levy, Oren; Phillips, Joseph P.; Stratton, Tara; Triana, Brian; Ruiz, Juan P.; Gu, Fangqi; Karp, Jeffrey M.; Lin, Charles P.en_US
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record